Last updated on September 2018

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses


Contact Investigators or Research Sites near you

Start Over

Michigan Medicine

Ann Arbor, MI United States
  Connect »

Abramson Cancer Center

Philadelphia, PA United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Fundaleu

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

Hospital General de Agudo Jose Maria Ramos Mejia

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

Royal North Shore Hospital

Saint Leonards, Australia
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Rostov State Medical University

Rostov-na-Donu, Russian Federation
  Connect »

Churchill Hospital

Oxford, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.